334 related articles for article (PubMed ID: 35197112)
1. YTHDF1 promotes breast cancer progression by facilitating FOXM1 translation in an m6A-dependent manner.
Chen H; Yu Y; Yang M; Huang H; Ma S; Hu J; Xi Z; Guo H; Yao G; Yang L; Huang X; Zhang F; Tan G; Wu H; Zheng W; Li L
Cell Biosci; 2022 Feb; 12(1):19. PubMed ID: 35197112
[TBL] [Abstract][Full Text] [Related]
2. Methylation recognition protein YTH N6-methyladenosine RNA binding protein 1 (YTHDF1) regulates the proliferation, migration and invasion of osteosarcoma by regulating m6A level of CCR4-NOT transcription complex subunit 7 (CNOT7).
Wei K; Gao Y; Wang B; Qu YX
Bioengineered; 2022 Mar; 13(3):5236-5250. PubMed ID: 35156522
[TBL] [Abstract][Full Text] [Related]
3. HIF-1α-induced expression of m6A reader YTHDF1 drives hypoxia-induced autophagy and malignancy of hepatocellular carcinoma by promoting ATG2A and ATG14 translation.
Li Q; Ni Y; Zhang L; Jiang R; Xu J; Yang H; Hu Y; Qiu J; Pu L; Tang J; Wang X
Signal Transduct Target Ther; 2021 Feb; 6(1):76. PubMed ID: 33619246
[TBL] [Abstract][Full Text] [Related]
4. ELK1-mediated YTHDF1 drives prostate cancer progression by facilitating the translation of Polo-like kinase 1 in an m6A dependent manner.
Li P; Shi Y; Gao D; Xu H; Zou Y; Wang Z; Li W
Int J Biol Sci; 2022; 18(16):6145-6162. PubMed ID: 36439881
[No Abstract] [Full Text] [Related]
5. YTHDF1 promotes hepatocellular carcinoma progression via activating PI3K/AKT/mTOR signaling pathway and inducing epithelial-mesenchymal transition.
Luo X; Cao M; Gao F; He X
Exp Hematol Oncol; 2021 Jun; 10(1):35. PubMed ID: 34088349
[TBL] [Abstract][Full Text] [Related]
6. The m6A readers
Anita R; Paramasivam A; Priyadharsini JV; Chitra S
Am J Cancer Res; 2020; 10(8):2546-2554. PubMed ID: 32905518
[TBL] [Abstract][Full Text] [Related]
7. The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation.
Liu T; Wei Q; Jin J; Luo Q; Liu Y; Yang Y; Cheng C; Li L; Pi J; Si Y; Xiao H; Li L; Rao S; Wang F; Yu J; Yu J; Zou D; Yi P
Nucleic Acids Res; 2020 Apr; 48(7):3816-3831. PubMed ID: 31996915
[TBL] [Abstract][Full Text] [Related]
8. HNRNPA2B1-mediated m6A modification of FOXM1 promotes drug resistance and inhibits ferroptosis in endometrial cancer via regulation of LCN2.
Jiang J; Zhu J; Qiu P; Ni J; Zhu W; Wang X
Funct Integr Genomics; 2023 Dec; 24(1):3. PubMed ID: 38091112
[TBL] [Abstract][Full Text] [Related]
9. The m
Chen XY; Liang R; Yi YC; Fan HN; Chen M; Zhang J; Zhu JS
Front Cell Dev Biol; 2021; 9():647702. PubMed ID: 33791305
[TBL] [Abstract][Full Text] [Related]
10. The N6-Methyladenosine (m6A) Methylation Gene
Liu T; Yang S; Cheng YP; Kong XL; Du DD; Wang X; Bai YF; Yin LH; Pu YP; Liang GY
Cancer Manag Res; 2020; 12():11953-11964. PubMed ID: 33244271
[TBL] [Abstract][Full Text] [Related]
11. METTL3 promotes non-small cell lung cancer (NSCLC) cell proliferation and colony formation in a m6A-YTHDF1 dependent way.
Dou X; Wang Z; Lu W; Miao L; Zhao Y
BMC Pulm Med; 2022 Aug; 22(1):324. PubMed ID: 36008805
[TBL] [Abstract][Full Text] [Related]
12. YTHDF1 Promotes Proliferation and Inhibits Apoptosis of Gastric Cancer Cells via Upregulating TCF7 mRNA Translation.
Li Y; Guo X; Liang X; Wang Z
Front Biosci (Landmark Ed); 2024 Mar; 29(3):117. PubMed ID: 38538279
[TBL] [Abstract][Full Text] [Related]
13. RNA N6-methyladenosine-modified-binding protein YTHDF1 promotes prostate cancer progression by regulating androgen function-related gene TRIM68.
Nie Q; Wu X; Huang Y; Guo T; Kuang J; Du C
Eur J Med Res; 2023 Dec; 28(1):552. PubMed ID: 38042806
[TBL] [Abstract][Full Text] [Related]
14. The m
Diao H; Tan H; Hu Y; Wang R; Cai P; Huang B; Shao X; Yan M; Yin C; Zhang Y
Pharmaceuticals (Basel); 2023 Jan; 16(2):. PubMed ID: 37259333
[TBL] [Abstract][Full Text] [Related]
15. The m6A methyltransferase METTL3 controls epithelial-mesenchymal transition, migration and invasion of breast cancer through the MALAT1/miR-26b/HMGA2 axis.
Zhao C; Ling X; Xia Y; Yan B; Guan Q
Cancer Cell Int; 2021 Aug; 21(1):441. PubMed ID: 34419065
[TBL] [Abstract][Full Text] [Related]
16. YTHDF1 promotes gallbladder cancer progression via post-transcriptional regulation of the m6A/UHRF1 axis.
Chen J; Bai X; Zhang W; Yan Z; Liu Y; Zhou S; Wu X; He X; Yang A
J Cell Mol Med; 2024 May; 28(9):e18328. PubMed ID: 38683130
[TBL] [Abstract][Full Text] [Related]
17. HIF-1α-induced expression of the m6A reader YTHDF1 inhibits the ferroptosis of nucleus pulposus cells by promoting SLC7A11 translation.
Lu X; Li D; Lin Z; Gao T; Gong Z; Zhang Y; Wang H; Xia X; Lu F; Song J; Xu G; Jiang J; Ma X; Zou F
Aging Cell; 2024 May; ():e14210. PubMed ID: 38783692
[TBL] [Abstract][Full Text] [Related]
18. Identification and Validation of the N6-Methyladenosine RNA Methylation Regulator YTHDF1 as a Novel Prognostic Marker and Potential Target for Hepatocellular Carcinoma.
Bian S; Ni W; Zhu M; Song Q; Zhang J; Ni R; Zheng W
Front Mol Biosci; 2020; 7():604766. PubMed ID: 33363211
[No Abstract] [Full Text] [Related]
19. YTHDF1-enhanced iron metabolism depends on TFRC m
Ye J; Wang Z; Chen X; Jiang X; Dong Z; Hu S; Li W; Liu Y; Liao B; Han W; Shen J; Xiao M
Theranostics; 2020; 10(26):12072-12089. PubMed ID: 33204330
[No Abstract] [Full Text] [Related]
20. METTL3 enhances the effect of YTHDF1 on NEDD1 mRNA stability by m6A modification in diffuse large B-cell lymphoma cells.
Feng L; Yan Q; Pan H; Shi W
Immun Inflamm Dis; 2023 Feb; 11(2):e789. PubMed ID: 36840486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
